Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:michaelbing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM To compare the Barcelona Clinic Liver Cancer(BCLC) and Hong Kong Liver Cancer(HKLC) classification systems when applied to HCC patients from the largest tertiary-level centre in Singapore.METHODS One thousand two hundred and seventy hepatocellular carcinoma(HCC) patients prospectively enrolled in a tertiary-level centre registry in Singapore since 1988 were studied. Patients were grouped into their respective BCLC and HKLC stages. Data such as demography, aetiology of HCC and type of treatment were collected. Survival data was based on census with the National Registry of Births and Deaths on 31 st October 2015. Statistical analyses were done using SPSS version 21(Chicago, IL, United States). Survival analyses were done by the Kaplan-Meier method. Differences in survival rates were compared using the log-rank test.RESULTS The median age at presentation was 63 years(range 13-94); male 82.4%; Chinese 89.4%, Malay 7.1%, Indian, 2.8%. Hepatitis B was the predominant aetiology(75.0%; Hepatitis C 7.2%, Hepatitis B and C co-infection 3.8%, non-viral 14.0%). Both BCLC and HKLC staging systems showed good separation with overall log rank test confirming significant survival differences between stages in our cohort(P < 0.001). 206 out of the 240 patients(85.8%) assigned for curative treatment by the BCLC treatment algorithm received curative therapy for HCC [Stage 0 93.2%(68/73); Stage A 82.6%(138/167)]. In contrast, only 341/558(61.1%) patients received curative treatment despite being assigned for curative treatment by the HKLC treatment algorithm [Stage Ⅰ 72.7%(264/363); Stage Ⅱ 40.2%(66/164); Stage Va 35.5%(11/31)]. Patients who were assigned to curative treatment by HKLC but did not receive curative treatment had significantly poorer ECOG(P < 0.001), higher ChildPugh status(P < 0.001) and were older(median age 66 vs 61, P < 0.001) than those who received curative therapy. Median overall survival in patients assigned to curative treatment groups by BCLC and HKLC were 6.1 and 2.6 years respectively(P < 0.001). When only patients receiving curative treatment were analyzed, BCLC still predicted overall median survival better than HKLC(7.1 years vs 5.5 years, P = 0.037). CONCLUSION BCLC performs better than HKLC in our multiethnic Asian population in allocating patients to curative treatment in a real-life situation as well as in predicting survival. AIM To compare the Barcelona Clinic Liver Cancer (BCLC) and Hong Kong Liver Cancer (HKLC) classification systems when applied to HCC patients from the largest tertiary-level center in Singapore. METHODS One thousand two hundred and seventy hepatocellular carcinoma (HCC) patients prospectively enrolled in a tertiary-level center registry in Singapore since 1988 were studied. Patients were grouped into their respective BCLC and HKLC stages. Data such as demography, aetiology of HCC and type of treatment were collected. Survival data was based on census with the National Registry of Births and Deaths on 31 st October 2015. Statistical analyzes were done using SPSS version 21 (Chicago, IL, United States). Survival analyzes were done by the Kaplan-Meier method. Differences in survival rates were compared using the log-rank test.RESULTS The median age at presentation was 63 years (range 13-94); male 82.4%; Chinese 89.4%, Malay 7.1%, Indian, 2.8%. Hepatitis B was the predominant aetiology (75.0%; He patitis C 7.2%, Hepatitis B and C co-infection 3.8%, non-viral 14.0%). Both BCLC and HKLC staging systems showed good separation with overall log rank test confirming significant survival differences between stages in our cohort (P <0.001) . 206 out of the 240 patients (85.8%) assigned for curative treatment by the BCLC treatment algorithm received curative therapy for HCC [Stage 0 93.2% (68/73); Stage A 82.6% (138/167)]. In contrast, only 341/558 (61.1%) patients received curative treatment despite being assigned for curative treatment by the HKLC treatment algorithm [Stage I 72.7% (264/363); Stage II 40.2% (66/164); Stage Va 35.5% (11 / 31)]. Patients who were assigned to curative treatment by HKLC but did not receive curative treatment had significantly poorer ECOG (P <0.001), higher ChildPugh status (P <0.001) and older (median age 66 vs 61, P < 0.001) than those who received curative therapy. Median overall survival in patients assigned to curative treatment groups by BCLC and HKLC w ereBCLC still predicted overall median survival better than HKLC (7.1 years vs 5.5 years, P = 0.037). CONCLUSION BCLC performs better than HKLC in our multiethnic Asian population in allocating patients to curative treatment in a real-life situation as well as in predicting survival.
其他文献
为鉴定非洲猪瘟病毒(ASFV) p54蛋白的B细胞线性抗原表位,本研究利用生物信息学方法结合抗原指数对ASFV p54蛋白进行抗原表位的预测,人工合成预测的抗原表位多肽,利用ASFV阳性
“在中国做企业与国外不同,国外企业只要专攻生产链中的一环就行,而中国企业则需要从源头开始,换句话说,就是从剪羊毛开始,一直到制成羊绒衫,每个环节,都要经过工厂的生产流
为了应对当前互联网存在的各种挑战,国际上热门的研究思路之一是重新构建一个以信息为中心的新型网络(ICH),而内容中心网络(CCN)正是其中的一种。CCN中每个路由节点都具有缓
南湖,位于浙江省嘉兴市区东南,风景秀丽,历史悠久,犹如一颗璀璨晶莹的明珠,镶嵌在杭嘉湖平原中。然而今天的南湖如此闻名遐迩、举世瞩目,是因为在南湖曾经发生了一件中国现代
忙忙忙,新闻采编人员平时确实忙。白天采访忙,晚上发稿忙,空闲构思忙,哪有时间归纳总结写文章,那我们宝贵的采写体会和理论思考怎样才能得到疏理总结和表达呢?最好的办法就是
目的检测HIV-1中枢特征性突变对中和抗体的中和敏感性,探讨其发生免疫逃逸的可能性。方法构建含有S446T、F396N、K429G、K337G、T319A、Q389K和N407T突变的HIV-1包膜假病毒,测定其感染靶细胞能力、对代表性广谱单克隆中和抗体PGT121、PGT135、VRC01、2G12、10E8和12A21的中和敏感性,分子构象模拟突变如何影响中和抗体的中和效果。结果7种突变假病毒
电磁层析成像(Electromagnetic Tomography,EMT)是近年来发展起来的一种电学层析成像(Electrical Tomography,ET)技术,它具有非侵入,非接触及无危害的优点,并对导电和导磁物质均有敏感性,因此在工业生产过程和生物医学领域都有应用的前景。EMT技术基于电磁感应原理,在外加交变电流引起的激励主磁场的作用下,物场中的导电媒质会产生感应涡流,导磁媒质会被磁化产
钢铁行业是我国的传统支柱产业,是国民经济建设的重要组成部分,而厚度是带钢重要的质量指标之一,其偏差直接影响到带钢的市场占有率。IMS测厚仪因其具有可靠性和测量精度高的
6月20日至21日,推进党的先进性建设研讨会在寿光举行。来自中央组织部、中央党校、国家行政学院、全国党建研究会、求是杂志社、浦东干部学院、井冈山干部学院和部分省(区、
随着社会生产力的高速发展,环境恶化与能源短缺问题日益严重,寻找高效清洁能源及其有效使用方法具有十分重要的意义,天然气作为三大能源之一,近年来得到越来越多的重视。燃气发动